Anke Waha

Koeln, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Spectrum of double heterozygosity in individuals diagnosed with hereditary breast and ovarian cancer.

Spectrum of double heterozygosity in individuals diagnosed with hereditary breast and ovarian cancer.

Journal: European journal of cancer (Oxford, England : 1990)
Published: April 24, 2026

Online Training to Increase Genetic and Risk Literacy in Physicians Counseling Breast and Ovarian Cancer Patients for Genetic Testing.

Online Training to Increase Genetic and Risk Literacy in Physicians Counseling Breast and Ovarian Cancer Patients for Genetic Testing.

Journal: Breast care (Basel, Switzerland)
Published: October 30, 2024

Implementing mainstream genetic counseling within the area-wide network of the German Consortium Hereditary Breast and Ovarian Cancer (GC-HBOC): Satisfaction of primary care providers with the provided state-of-the-art training by the Cologne Center.

Implementing mainstream genetic counseling within the area-wide network of the German Consortium Hereditary Breast and Ovarian Cancer (GC-HBOC): Satisfaction of primary care providers with the provided state-of-the-art training by the Cologne Center.

Journal: Journal of genetic counseling
Published: October 08, 2022

Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer.

Prevalence of Pathogenic Germline Variants in Women with Non-Familial Unilateral Triple-Negative Breast Cancer.

Journal: Breast care (Basel, Switzerland)
Published: August 19, 2022

HerediCaRe: Documentation and IT Solution of a Specialized Registry for Hereditary Breast and Ovarian Cancer

HerediCaRe: Documentation and IT Solution of a Specialized Registry for Hereditary Breast and Ovarian Cancer

Journal: Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))
Published: November 03, 2021

Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility.

Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia-like phenotype, and no chromosome fragility.

Journal: Molecular genetics & genomic medicine
Published: June 06, 2019

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

Journal: Human mutation
Published: January 30, 2019

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history.

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history.

Journal: BMC cancer
Published: April 27, 2017

MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motility.

MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motility.

Journal: Translational oncology
Published: May 13, 2016

Altered splicing leads to reduced activation of CPEB3 in high-grade gliomas.

Altered splicing leads to reduced activation of CPEB3 in high-grade gliomas.

Journal: Oncotarget
Published: December 17, 2015

Analysis of TET expression/activity and 5mC oxidation during normal and malignant germ cell development.

Analysis of TET expression/activity and 5mC oxidation during normal and malignant germ cell development.

Journal: PloS one
Published: August 15, 2013

KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas.

KIAA1797/FOCAD encodes a novel focal adhesion protein with tumour suppressor function in gliomas.

Journal: Brain : a journal of neurology
Published: March 20, 2012
Showing 1-12 of 14

Last Updated: 09/26/2026